Princeton, NJ, United States of America

Praveen Kumar Subbappa

USPTO Granted Patents = 12 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 115(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Praveen Kumar Subbappa

Introduction

Praveen Kumar Subbappa, based in Princeton, NJ, is a notable inventor with a strong focus on pharmaceutical innovations. With a remarkable nine patents to his name, he has made significant contributions to the field of medication formulation, particularly involving apixaban, a drug used for blood thinning. His work reflects a commitment to improving patient care through innovative pharmaceutical solutions.

Latest Patents

Subbappa's most recent patents highlight his efforts to create stable pharmaceutical compositions of apixaban. The first invention details formulations that comprise apixaban or its pharmaceutically acceptable salts. These compositions are designed as capsule forms containing a therapeutically effective amount of apixaban, ranging from about 0.5 mg to about 50 mg per unit dosage. The second patent addresses the stability of oral liquid pharmaceutical compositions of apixaban, specifically stable formulations that can maintain efficacy over extended periods. These innovative liquid compositions, with concentrations of 0.4 mg/mL or more, are essential for administering treatment for various disorders treatable with apixaban.

Career Highlights

Praveen Kumar Subbappa currently holds a prominent position at Slayback Pharma LLC, where he contributes to the development of innovative pharmaceutical products. His journey in the pharmaceutical industry is marked by a strong emphasis on creating effective and stable drug formulations that cater to patient needs.

Collaborations

Throughout his career, Subbappa has worked alongside skilled professionals such as Ajay Kumar Singh and Hanimi Reddy Bapatu. Collaborating with talented colleagues has enabled him to enhance the scope and impact of his innovations, fostering a creative environment for developing cutting-edge pharmaceutical solutions.

Conclusion

Praveen Kumar Subbappa exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the formulation of stable compositions of apixaban, stand as a testament to his dedication to improving healthcare. As he continues to advance in his field, his work will likely lead to further enhancements in pharmaceutical therapies and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…